A retrospective database analysis of patients with chronic hepatitis C virus (HCV) infection who have chronic kidney disease were administered elbasvir/grazoprevir (ZEPATIER) in the US Department of Veterans Affairs (VA) healthcare system

Trial Profile

A retrospective database analysis of patients with chronic hepatitis C virus (HCV) infection who have chronic kidney disease were administered elbasvir/grazoprevir (ZEPATIER) in the US Department of Veterans Affairs (VA) healthcare system

Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Jun 2018

At a glance

  • Drugs Elbasvir/grazoprevir (Primary)
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Jun 2018 Results (n=4755) presented at the Digestive Disease Week 2018.
    • 14 Apr 2018 Results (n=4755) presented at The International Liver Congress 2018.
    • 14 Apr 2018 Results (n=4755) assessing the effect of acid-reducing agents use on SVR presented at The International Liver Congress 2018
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top